Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum creatinine to cystatin C ratio as a biomarker for monitoring motor-function in children with spinal muscular atrophy treated with nusinersen: a retrospective cohort study. | BMC Neurol | 2026 | 41580653 | PubTator, text mining | PubMed |
| Neural correlates of joint attention in infants aged 8-24 months: A systematic review. | Dev Cogn Neurosci | 2026 | 41576764 | PubTator, text mining | PubMed |
| Liver Steatosis in Induced Hepatocytes From Carriers of Spinal Muscular Atrophy. | Muscle Nerve | 2026 | 41567114 | PubTator, text mining | PubMed |
| Targeted Carrier Screening for Thalassemia, Hereditary Deafness, and Spinal Muscular Atrophy: A Feasible Approach for Preventing Birth Defects in China's Community Healthcare System. | Mol Genet Genomic Med | 2026 | 41566141 | PubTator, text mining | PubMed |
| Plasma Neurofilament Light Chain as a Potential Biomarker of Presymptomatic Spinal Muscular Atrophy. | Muscle Nerve | 2026 | 41556253 | PubTator, text mining | PubMed |
| A therapeutic antisense oligonucleotide encompassing 2'-O-methoxyethyl modification triggers unique perturbation of the transcriptome. | NAR Mol Med | 2026 | 41551726 | PubTator, text mining | PubMed |
| Scoliosis correction in spinal muscular atrophy : the influence of genetic severity, functional level, and disease-modifying agents on postoperative outcomes. | Bone Jt Open | 2026 | 41542782 | PubTator, text mining | PubMed |
| Impaired renal function in patients with spinal muscular atrophy: A longitudinal cohort study. | J Neuromuscul Dis | 2026 | 41540943 | PubTator, text mining | PubMed |
| Using RNA-targeting CRISPR-Cas13 and engineered U1 systems to target ABCA4 splice variants in Stargardt disease. | Mol Ther Nucleic Acids | 2026 | 41536809 | PubTator, text mining | PubMed |
| SDrecall: a sensitive approach for variant detection in segmental duplications. | Genome Biol | 2026 | 41526966 | PubTator, text mining | PubMed |
| Proband-independent noninvasive prenatal diagnosis for spinal muscular atrophy: early detection paving the way for early prenatal treatment. | Ann Med | 2026 | 41489856 | PubTator, text mining | PubMed |
| Clinically discordant siblings with spinal muscular atrophy: insights from their patient-specific iPSC-derived motor neurons and literature review. | Neuromuscul Disord | 2026 | 41447746 | PubTator, text mining | PubMed |
| Treatment evolution in spinal muscular atrophy: insights from the SMArtCARE registry. | Brain | 2026 | 41431300 | PubTator, text mining | PubMed |
| A More Clinically Effective Long-Read Sequencing-Based Approach for Comprehensive Analysis of Spinal Muscular Atrophy. | J Mol Diagn | 2026 | 41265786 | PubTator, text mining | PubMed |
| Concurrent diagnosis of spinal muscular atrophy and trisomy 21: Value of comprehensive analysis in prenatal genetic testing. | Clin Chim Acta | 2026 | 41240977 | PubTator, text mining | PubMed |
| Onasemnogene abeparvovec gene therapy for treatment of patients with spinal muscular atrophy: Updated real-world practical considerations. | J Neuromuscul Dis | 2026 | 41212681 | PubTator, text mining | PubMed |
| Real-world evidence on nusinersen treatment of persons with SMA: a focused review. | J Neuromuscul Dis | 2026 | 41137787 | PubTator, text mining | PubMed |
| Updates of spinal muscular atrophy in advanced therapies. | J Formos Med Assoc | 2026 | 41109767 | PubTator, text mining | PubMed |
| DG9-Conjugated Morpholino Rescues Phenotype in Spinal Muscular Atrophy Mice. | Methods Mol Biol | 2026 | 41028674 | PubTator, text mining | PubMed |
| Phenotypic intrafamilial variability of 5q-associated spinal muscular atrophy: A systematic multicentre sibling study. | J Neuromuscul Dis | 2026 | 40938628 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=6